Prevalence and clinical risk factors for methotrexate intolerance in patients with juvenile idiopathic arthritis
{{output}}
Aims: Methotrexate (MTX) is a basic therapy for juvenile idiopathic arthritis (JIA). MTX intolerance can significantly impact quality of life, treatment adherence and outcomes. We aimed to assess the prevalence of MTX intolerance... ...
